MALARVX, INC.
SEATTLE, WA · Founded 2012 · CIK 0001559688 · Biotech · Private
In vitro culture system for producing Plasmodium falciparum sporozoites for malaria vaccine development
malarvx.com →- Grants
- $447K
- 2 awards
- Sector median: 1
- Raised
- $235K
- 4 Form D · Aug 2026
- 2 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201120132015201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $110,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Biological Equivalence of In Vitro Plasmodium falciparum Culture for Practical Malaria Vaccine Development | $230,288 | |
| Federal grant | Department of Health and Human Services · Phase I · Biological Equivalence of In Vitro Plasmodium falciparum Culture for Practical Malaria Vaccine Development | $217,162 | |
| Private capital raised | Form D · SEC | $125,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2944 | Rayaldee | — | — |
| 2945 | EPITUNE LLC | — | — |
| 2946 | Atropos Therapeutics, Inc. | — | — |
| 2947 | MALARVX, INC. | — | $235K |
| 2948 | ENEPRET, INC. | — | — |
| 2949 | Vitanova Biomedical, Inc. | — | $8.0M |
| 2950 | OnCusp Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- James DavieDirector · Executive Officer
Patents
- Compositions, Devices, Systems And Methods Relating To Vaccination And Sterile Protection Against Malariaapplication
- Compositions, Devices, Systems And Methods Relating To Vaccination And Sterile Protection Against Malariaapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.